Asian Journal of Psychiatry
Volume 1, Issue 2 , Pages 22-27 , December 2008

Nosological status and definition of schizophrenia: Some considerations for DSM-V and ICD-11

References 

  1. Allardyce J, Suppes T, Van Os J. Dimensions and the psychosis phenotype. Int. J. Methods Psychiatric Res. 2007;16(Suppl 1):S34–40
  2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 1st edition (DSM-II). Washington, DC: American Psychiatric Association; 1952;
  3. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 2nd edition (DSM-II). Washington, DC: American Psychiatric Association; 1968;
  4. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (DSM-III). Washington, DC: American Psychiatric Association; 1980;
  5. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (revised). Washington, DC: American Psychiatric Association; 1987;
  6. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association; 1994;
  7. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th edition (text revision) (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000;
  8. Andreasen NC. DSM and the death of phenomenology in America: an example of unintended consequences. Schizophr. Bull. 2007;33:108–112
  9. Bentall R. Madness explained: why we must reject the Kraepelinian paradigm and replace it with a ‘complaint-orientated’ approach to understanding mental illness. Med. Hypoth. 2006;66:220–233
  10. Bertillon J. Classification of the causes of death. In: Transactions of the 15th International Congress of Hygiene Demography. Washington, DC. 1912;
  11. Bleuler E. Dementia Praecox or the Group of Schizophrenias [1911]. New York: International University Press; 1950;
  12. Boyle M. Is schizophrenia what it was? A re-analysis of Kraeplin’s and Bleuler’s population. J. History Behav. Sci. 1990;26:323–333
  13. Braff DL, Freedman R, Schork NJ, Gottesman II. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr. Bull. 2007;33:21–32
  14. Cheniaux E, Landeira-Fernandez J, Lessa Telles L, Lessa JL, Dias A, Duncan T, et al. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. J. Affective Disord. 2008;106:209–217
  15. Chong SA. Inclusion of cognitive impairment in the DSM diagnosis of schizophrenia: if not now, when?. World Psychiatry. 2008;7:37–38
  16. Cooper J, Kendell R, Gurland B, Sharp L, et al. Psychiatric diagnosis in New York and London. Oxford: Oxford University Press; 1972;
  17. Fiedorowicz JG, Epping EA, Flaum M. Toward defining schizophrenia as a more useful clinical concept. Curr. Psychiatry Rep. 2008;10:344–351
  18. Gold JM. Is cognitive impairment in schizophrenia ready for diagnostic prime time?. World Psychiatry. 2008;7:32–33
  19. Harvey PD. Cognition and the differential diagnosis of schizophrenia. World Psychiatry. 2008;7:30–32
  20. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am. J. Psychiatry. 1994;151:1409–1416
  21. Helmes E, Landmark J. Subtypes of schizophrenia: a cluster analytic approach. Can. J. Psychiatry. 2003;48:702–708
  22. Hoenig J. The concept of Schizophrenia Kraepelin-Bleuler-Schneider. Br. J. Psychiatry. 1983;142:547–556
  23. Jager M, Bottlender R, Strauss A, Moller HJ. Fifteen-year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders. Acta Psychiatrica Scandinavica. 2004;109:30–37
  24. Jansson LB, Parnas J. Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?. Schizophr. Bull. 2007;33:1178–1200
  25. Keefe R. Should cognitive impairment be included in the diagnostic criteria for schizophrenia?. World Psychiatry. 2008;7:22–28
  26. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am. J. Psychiatry. 2003;160:4–12
  27. Keshavan MS, Prasad KM, Pearlson G. Are brain structural abnormalities useful as endophenotypes in schizophrenia?. Int. Rev. Psychiatry (Abingdon, England). 2007;19:397–406
  28. Keshavan MS, Tandon R, Boutros NN, Nasrallah HA. Schizophrenia “just the facts”: What we know in 2008, Part 3: Neurobiology.. Schizophr. Res. 2008;
  29. Kraepelin E. Demential Praecox and Paraphrenia [1919]. New York: Robert E. Krieger Publishing Corporation; 1971;
  30. Maier W. Do schizoaffective disorders exist at all?. Acta Psychiatrica Scandinavica. 2006;113:369–371
  31. Maj M. Are we able to differentiate between true mental disorders and homeostatic reactions to adverse list events?. Psychother. Psychosom. 2000;76:257–259
  32. Maj M. Psychiatric comorbidity”: an artefact of current diagnostic systems?. Br. J. Psychiatry. 2005;186:182–184
  33. Maj M, Pirozzi R, Formicola AM, Bartoli L, Bucci P. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. J. Affective Disord. 2000;57:95–98
  34. Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord. 2008;10:215–230
  35. Merriam-Webster. Online Dictionary, “nosology”. Retrieved October 8, 2008, from http://www.merriam-webster.com/dictionary/nosology.
  36. Menuck M. What did Eugen Bleuler really say?. Can. J. Psychiatry. 1979;24:161–166
  37. Morrison JR. Changes in subtype diagnosis of schizophrenia: 1920–1966. Am. J. Psychiatry. 1974;131:674–677
  38. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.. Arch. Gen. Psychiatry. 1994;51:849–859discussion 863–844
  39. Peralta V, Cuesta MJ. The nosology of psychotic disorders: a comparison among competing classification systems. Schizophr. Bull. 2003;29:413–425
  40. Pope HG, Lipinski JF. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of ‘schizophrenic’ symptoms in the light of current research. Arch. Gen. Psychiatry. 1978;35:811–828
  41. Regier DA. Time for a fresh start? Rethinking psychosis in DSM-V. Schizophr. Bull. 2007;33:843–845
  42. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am. J. Psychiatry. 1970;126:983–987
  43. Schneider K. Clinical Psychopathology. New York: Grune and Stratton; 1959;
  44. Schwartz JE, Fennig S, Tanenberg-Karant M, Carlson G, Craig T, Galambos N, et al. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch. Gen. Psychiatry. 2000;57:593–600
  45. Stompe T, Ortwein-Swoboda G, Ritter K, Schanda H, Friedmann A. Are we witnessing the disappearance of catatonic schizophrenia?. Comprehensive Psychiatry. 2002;43:167–174
  46. Tandon R, Targum SD, Nasrallah HA, Ross R. Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. J. Psychiatric Pract. 2006;12:348–363
  47. Tandon R, Belmaker RH, Gattaz WF, Lopez-Ibor JJ, Okasha A, Singh B, et al. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr. Res. 2008;100:20–38
  48. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia “just the facts” what we know in 2008. 2. Epidemiology and etiology. Schizophr. Res. 2008;102:1–18
  49. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia “Just the Facts”: what we know in 2008 part 1: overview.. Schizophr. Res. 2008;100:4–19
  50. Ustun TB, Goldberg D, Cooper J, et al. New classification for mental disorders with management guidelines for use in primary care: ICD-10 PHC chapter five. Br. J. Gen. Pract. 1995;45:211–215
  51. Vollmer-Larsen A, Jacobsen TB, Hemmingsen R, Parnas J. Schizoaffective disorder—the reliability of its clinical diagnostic use. Acta Psychiatrica Scandinavica. 2006;113:402–407
  52. Weder ND, Muralee S, Penland H, Tampi RR. Catatonia: a review. Ann. Clin. Psychiatry. 2008;20:97–107
  53. Whitehead C, Moss S, Cardno A, Lewis G. Antidepressants for the treatment of depression in people with schizophrenia: a systematic review. Psychol. Med. 2003;33:589–599
  54. Wing JK. Abandoning what?. Br. J. Clin. Psychol. Br. Psychol. Soc. 1988;27(Pt 4):325–328
  55. World Health Organization . Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. Geneva: World Health Organization; 1949;
  56. World Health Organization . The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines (CDDG). Geneva: World Health Organization; 1992;
  57. World Health Organization . The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research (DCR-10). Geneva: World Health Organization; 1993;

PII: S1876-2018(08)00029-4

doi: 10.1016/j.ajp.2008.10.002

Asian Journal of Psychiatry
Volume 1, Issue 2 , Pages 22-27 , December 2008

Article Tools

* Image Usage & Resolution